You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?

Article info

Article menu
XML
Chronic obstructive pulmonary disease
Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?

Authors

  • Lianne Parkin Department of Preventive and Social Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New ZealandPharmacoepidemiology Research Network, University of Otago, Dunedin, New Zealand PubMed articlesGoogle scholar articles
  • Sheila Williams Department of Preventive and Social Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New Zealand PubMed articlesGoogle scholar articles
  • David Barson Department of Preventive and Social Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New ZealandPharmacoepidemiology Research Network, University of Otago, Dunedin, New Zealand PubMed articlesGoogle scholar articles
  • Katrina Sharples Pharmacoepidemiology Research Network, University of Otago, Dunedin, New ZealandDepartment of Mathematics and Statistics, University of Otago, Dunedin, New ZealandDepartment of Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New Zealand PubMed articlesGoogle scholar articles
  • Simon Horsburgh Department of Preventive and Social Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New ZealandPharmacoepidemiology Research Network, University of Otago, Dunedin, New Zealand PubMed articlesGoogle scholar articles
  • Rod Jackson Department of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand PubMed articlesGoogle scholar articles
  • Jack Dummer Pharmacoepidemiology Research Network, University of Otago, Dunedin, New ZealandDepartment of Medicine, Otago Medical School - Dunedin Campus, University of Otago, Dunedin, New Zealand PubMed articlesGoogle scholar articles
  1. Correspondence to Associate Professor Lianne Parkin; lianne.parkin{at}otago.ac.nz
View Full Text

Citation

Parkin L, Williams S, Barson D, et al
Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?
BMJ Open Respiratory Research 2021;8:e000840. doi: 10.1136/bmjresp-2020-000840

Publication history

  • Received November 22, 2020
  • Revised December 3, 2020
  • Accepted December 7, 2020
  • First published January 25, 2021.
Online issue publication 
July 13, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.